4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-044893
See Remarks sold 465 shares at $17.99 ($8,365)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lynch Ryan See Remarks | 2026-06-22 | Sale 10b5-1 | −465 | $17.99 | $8,365 | 13,871 | D |
| Open-market sales · 465 sh · avg $17.99 · $8,365 | |||||||
Loading xslF345X06/wk-form4_1782245092.xml…